Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
By Rocky Swift TOKYO, May 14 (Reuters) - Bain Capital-owned Tanabe Pharma plans to bring up to three new drugs to Japan each year as the former Mitsubishi Chemical unit doubles down on its home market ...
As tariff threats and FDA staff cuts thrust the biopharma world into uncharted waters, President Donald Trump is offering the industry some reprieve by ordering the elimination of the so-called "pill ...
Peer-reviewed publication highlights preclinical findings demonstrating weight loss, lipid normalization, and reduction ...
President Donald Trump has signed an executive order on prescription drug prices that walks back the "pill penalty" decried by PhRMA in President Joe Biden's Inflation Reduction Act. In the executive ...
This podcast transcript is generated by third-party AI. It has not been reviewed prior to publication. We make no representations or warranties in relation to the transcript, its accuracy or its ...
If last year’s pharma ad showing during the Super Bowl drove buzzy conversation and a touch of controversy, the lasting impression pharma marketers made on consumers during Sunday’s Super Bowl LX took ...
Bristol Myers Squibb (BMS) will partner with Hengrui Pharma to co-develop 13 early-stage programs in oncology, hematology, and immunology, through a collaboration that could generate more than $15.2 ...
Rigel Pharmaceuticals Inc. RIGL stock is trading higher on Tuesday as the company is entering an exclusive global licensing ...
Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, announces that it has been named a winner of the 2026 GHP Magazine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results